Suppression of NK Cell Activation by JAK3 Inhibition: Implication in the Treatment of Autoimmune Diseases

Overview

Journal J Immunol Res

Publisher Wiley

Specialty Allergy & Immunology

Date 2023 Dec 18

PMID 38106519

Authors

Wai Chung Wu

Carol Shiu

Tak Keung Tong

Shui On Leung

Chin Wai Hui

Affiliations

Soon will be listed here.

Abstract

Natural killer (NK) cell is an essential cytotoxic lymphocyte in our innate immunity. Activation of NK cells is of paramount importance in defending against pathogens, suppressing autoantibody production and regulating other immune cells. Common gamma chain (c) cytokines, including IL-2, IL-15, and IL-21, are defined as essential regulators for NK cell homeostasis and development. However, it is inconclusive whether c cytokine-driven NK cell activation plays a protective or pathogenic role in the development of autoimmunity. In this study, we investigate and correlate the differential effects of c cytokines in NK cell expansion and activation. IL-2 and IL-15 are mainly responsible for NK cell activation, while IL-21 preferentially stimulates NK cell proliferation. Blockade of Janus tyrosine kinase/signal transducer and activator of transcription (JAK/STAT) signaling pathway by either JAK inhibitors or antibodies targeting c receptor subunits reverses the c cytokine-induced NK cell activation, leading to suppression of its autoimmunity-like phenotype . These results underline the mechanisms of how c cytokines trigger autoimmune phenotype in NK cells as a potential target to autoimmune diseases.

Citing Articles

Cancer Risk in IBD Patients Treated with JAK Inhibitors: Reassuring Evidence from Trials and Real-World Data.

Puca P, Del Gaudio A, Iaccarino J, Blasi V, Coppola G, Laterza L Cancers (Basel). 2025; 17(5).

PMID: 40075582 PMC: 11899451. DOI: 10.3390/cancers17050735.

Beyond CAR-T: The rise of CAR-NK cell therapy in asthma immunotherapy.

Mohammad Taheri M, Javan F, Poudineh M, Athari S J Transl Med. 2024; 22(1):736.

PMID: 39103889 PMC: 11302387. DOI: 10.1186/s12967-024-05534-8.

References

Konjevic G, Vuletic A, Mirjacic Martinovic K, Colovic N, Colovic M, Jurisic V . Decreased CD161 activating and increased CD158a inhibitory receptor expression on NK cells underlies impaired NK cell cytotoxicity in patients with multiple myeloma. J Clin Pathol. 2016; . DOI: 10.1136/jclinpath-2016-203614. View

Yang Y, Lundqvist A . Immunomodulatory Effects of IL-2 and IL-15; Implications for Cancer Immunotherapy. Cancers (Basel). 2020; 12(12). PMC: 7761238. DOI: 10.3390/cancers12123586. View

Sharief M, Thompson E . Correlation of interleukin-2 and soluble interleukin-2 receptor with clinical activity of multiple sclerosis. J Neurol Neurosurg Psychiatry. 1993; 56(2):169-74. PMC: 1014817. DOI: 10.1136/jnnp.56.2.169. View

Poggi A, Zocchi M . NK cell autoreactivity and autoimmune diseases. Front Immunol. 2014; 5:27. PMC: 3912987. DOI: 10.3389/fimmu.2014.00027. View

Waldmann T . The shared and contrasting roles of IL2 and IL15 in the life and death of normal and neoplastic lymphocytes: implications for cancer therapy. Cancer Immunol Res. 2015; 3(3):219-27. PMC: 4351780. DOI: 10.1158/2326-6066.CIR-15-0009. View

Mahida Y, Gallagher A, Kurlak L, Hawkey C . Plasma and tissue interleukin-2 receptor levels in inflammatory bowel disease. Clin Exp Immunol. 1990; 82(1):75-80. PMC: 1535179. DOI: 10.1111/j.1365-2249.1990.tb05406.x. View

Vuletic A, Jovanic I, Jurisic V, Milovanovic Z, Nikolic S, Spurnic I . IL-2 And IL-15 Induced NKG2D, CD158a and CD158b Expression on T, NKT- like and NK Cell Lymphocyte Subsets from Regional Lymph Nodes of Melanoma Patients. Pathol Oncol Res. 2018; 26(1):223-231. DOI: 10.1007/s12253-018-0444-2. View

Marcus A, Gowen B, Thompson T, Iannello A, Ardolino M, Deng W . Recognition of tumors by the innate immune system and natural killer cells. Adv Immunol. 2014; 122:91-128. PMC: 4228931. DOI: 10.1016/B978-0-12-800267-4.00003-1. View

Zamai L, Ahmad M, M Bennett I, Azzoni L, Alnemri E, Perussia B . Natural killer (NK) cell-mediated cytotoxicity: differential use of TRAIL and Fas ligand by immature and mature primary human NK cells. J Exp Med. 1998; 188(12):2375-80. PMC: 2212426. DOI: 10.1084/jem.188.12.2375. View

10.

de Jesus-Gil C, Sans-de San Nicolas L, Garcia-Jimenez I, Ferran M, Pujol R, Santamaria-Babi L . Human CLA Memory T Cell and Cytokines in Psoriasis. Front Med (Lausanne). 2021; 8:731911. PMC: 8585992. DOI: 10.3389/fmed.2021.731911. View

11.

Zhang C, Wang X, Li S, Twelkmeyer T, Wang W, Zhang S . NKG2A is a NK cell exhaustion checkpoint for HCV persistence. Nat Commun. 2019; 10(1):1507. PMC: 6447531. DOI: 10.1038/s41467-019-09212-y. View

12.

Mirjacic Martinovic K, Vuletic A, Lj Babovic N, Dzodic R, Konjevic G, Jurisic V . Attenuated in vitro effects of IFN-α, IL-2 and IL-12 on functional and receptor characteristics of peripheral blood lymphocytes in metastatic melanoma patients. Cytokine. 2017; 96:30-40. DOI: 10.1016/j.cyto.2017.02.024. View

13.

Higuma-Myojo S, Sasaki Y, Miyazaki S, Sakai M, Siozaki A, Miwa N . Cytokine profile of natural killer cells in early human pregnancy. Am J Reprod Immunol. 2005; 54(1):21-9. DOI: 10.1111/j.1600-0897.2005.00279.x. View

14.

Custurone P, Di Bartolomeo L, Irrera N, Borgia F, Altavilla D, Bitto A . Role of Cytokines in Vitiligo: Pathogenesis and Possible Targets for Old and New Treatments. Int J Mol Sci. 2021; 22(21). PMC: 8584117. DOI: 10.3390/ijms222111429. View

15.

Ferreira R, Simons H, Thompson W, Cutler A, Dopico X, Smyth D . IL-21 production by CD4+ effector T cells and frequency of circulating follicular helper T cells are increased in type 1 diabetes patients. Diabetologia. 2015; 58(4):781-90. PMC: 4351433. DOI: 10.1007/s00125-015-3509-8. View

16.

Tornroos H, Hagerstrand H, Lindqvist C . Culturing the Human Natural Killer Cell Line NK-92 in Interleukin-2 and Interleukin-15 - Implications for Clinical Trials. Anticancer Res. 2018; 39(1):107-112. DOI: 10.21873/anticanres.13085. View

17.

Park Y, Shin D, Cho D, Kim S, Lee J, Shin M . Interleukin-21 increases direct cytotoxicity and IFN-γ production of ex vivo expanded NK cells towards breast cancer cells. Anticancer Res. 2012; 32(3):839-46. View

18.

Vosshenrich C, Ranson T, Samson S, Corcuff E, Colucci F, Rosmaraki E . Roles for common cytokine receptor gamma-chain-dependent cytokines in the generation, differentiation, and maturation of NK cell precursors and peripheral NK cells in vivo. J Immunol. 2005; 174(3):1213-21. DOI: 10.4049/jimmunol.174.3.1213. View

19.

Curtis J, Yamaoka K, Chen Y, Bhatt D, Gunay L, Sugiyama N . Malignancy risk with tofacitinib versus TNF inhibitors in rheumatoid arthritis: results from the open-label, randomised controlled ORAL Surveillance trial. Ann Rheum Dis. 2023; 82(3):331-343. PMC: 9933177. DOI: 10.1136/ard-2022-222543. View

20.

Hao Y, Xie L, Xia J, Liu Z, Yang B, Zhang M . Plasma interleukin-21 levels and genetic variants are associated with susceptibility to rheumatoid arthritis. BMC Musculoskelet Disord. 2021; 22(1):246. PMC: 7936495. DOI: 10.1186/s12891-021-04111-0. View